Longer-Term Follow-Up of a Phase 2 Study (CheckMate 063) of Nivolumab in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer

Authors

Suresh G. Nair MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

9-2015

Volume

10

Issue

9

Published In/Presented At

https://doi.org/10.1016/S1556-0864(16)30010-7

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article